181 related articles for article (PubMed ID: 32426990)
1. Newer and Safer Kappa-Opioid Agonist for Your Patients With Uremic Pruritus.
Lagacé F; Jfri A; Litvinov IV; Netchiporouk E
J Cutan Med Surg; 2020; 24(5):525-526. PubMed ID: 32426990
[No Abstract] [Full Text] [Related]
2. Difelikefalin (Korsuva) for chronic kidney disease-associated pruritus.
Med Lett Drugs Ther; 2022 Feb; 64(1643):18-19. PubMed ID: 35134047
[No Abstract] [Full Text] [Related]
3. Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus.
Fugal J; Serpa SM
Ann Pharmacother; 2023 Apr; 57(4):480-488. PubMed ID: 35942600
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.
Yosipovitch G; Awad A; Spencer RH; Munera C; Menzaghi F
J Am Acad Dermatol; 2023 Aug; 89(2):261-268. PubMed ID: 37059302
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.
Lipman ZM; Yosipovitch G
Expert Opin Pharmacother; 2021 Apr; 22(5):549-555. PubMed ID: 33190563
[No Abstract] [Full Text] [Related]
6. Difelikefalin: First Approval.
Deeks ED
Drugs; 2021 Nov; 81(16):1937-1944. PubMed ID: 34674115
[TBL] [Abstract][Full Text] [Related]
7. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.
Fishbane S; Jamal A; Munera C; Wen W; Menzaghi F;
N Engl J Med; 2020 Jan; 382(3):222-232. PubMed ID: 31702883
[TBL] [Abstract][Full Text] [Related]
8. Intravenous difelikefalin for the treatment of hemodialysis pruritus.
Mahmoud RH; Mahmoud O; Yosipovitch G
Expert Rev Clin Immunol; 2024; 20(1):31-37. PubMed ID: 37847514
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the treatment of uremic pruritus.
Trachtenberg AJ; Collister D; Rigatto C
Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):465-470. PubMed ID: 32740217
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of difelikefalin in the treatment of hemodialysis patients with pruritus: A meta-analysis and systematic review.
Xue G; Yuan H; Fan D; Yang Y; Ma C; Liu J; Liao R
Clin Nephrol; 2024 Apr; 101(4):155-163. PubMed ID: 38294219
[TBL] [Abstract][Full Text] [Related]
11. Difelikefalin for pruritus associated with renal disease.
Manenti L; Fenaroli P
Drugs Today (Barc); 2022 Sep; 58(9):427-435. PubMed ID: 36102903
[TBL] [Abstract][Full Text] [Related]
12. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.
Nakao K; Mochizuki H
Drugs Today (Barc); 2009 May; 45(5):323-9. PubMed ID: 19584962
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
Mathur VS; Kumar J; Crawford PW; Hait H; Sciascia T;
Am J Nephrol; 2017; 46(6):450-458. PubMed ID: 29253847
[TBL] [Abstract][Full Text] [Related]
14. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis.
Rastogi A; Fishbane S; Lerma E
Expert Rev Clin Pharmacol; 2023 May; 16(5):387-400. PubMed ID: 37010031
[TBL] [Abstract][Full Text] [Related]
15. Difelikefalin for Hemodialysis Patients with Pruritus in Japan.
Narita I; Tsubakihara Y; Takahashi N; Ebata T; Uchiyama T; Marumo M; Okamura S; Gejyo F;
NEJM Evid; 2023 Nov; 2(11):EVIDoa2300094. PubMed ID: 38320524
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients.
Rossi GM; Corradini M; Blanco V; Mattei S; Fiaccadori E; Vaglio A; Manenti L
Intern Emerg Med; 2019 Nov; 14(8):1341-1346. PubMed ID: 31494816
[No Abstract] [Full Text] [Related]
17. [Uremic pruritus: an unresolved challenge].
Aucella F; Gesuete A
G Ital Nefrol; 2009; 26(5):585-99. PubMed ID: 19802804
[TBL] [Abstract][Full Text] [Related]
18. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].
Nakao K; Ando A; Hirakata M; Ando N; Takeshita K; Miyamoto Y; Mochizuki H
Nihon Yakurigaku Zasshi; 2010 May; 135(5):205-14. PubMed ID: 20467170
[No Abstract] [Full Text] [Related]
20. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.
Makhlough A; Ala S; Haj-Heydari Z; Kashi Z; Bari A
Iran J Kidney Dis; 2010 Apr; 4(2):137-40. PubMed ID: 20404425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
